Lopinavir - PDFSEARCH.IO - Document Search Engine

Lopinavir
Results: 160

#	Item
31	These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA.LEXIVA (fosamprenavir calcium) Tablets, for oral useLEXIVA (fosamprenavir calci Add to Reading List Source URL: www.fda.gov Language: English Ritonavir Lopinavir Antiretroviral drug Delavirdine Fosamprenavir Nelfinavir Darunavir Atazanavir Protease inhibitors Chemistry Organic chemistry
32	Revised requirements for accepting second line TB product dossiers for assessment: Add to Reading List Source URL: apps.who.int Language: English - Date: 2012-03-21 10:26:16 Protease inhibitors Alcohols Lopinavir Dry powder inhaler Medicine Pharmacology Chemistry
33	IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr REYATAZ * Add to Reading List Source URL: www.bmscanada.ca Language: English - Date: 2013-10-09 11:53:01 Lactams PDE5 inhibitors Piperazines Carbamates Tadalafil Sildenafil Lopinavir/ritonavir Atazanavir Efavirenz Chemistry Organic chemistry Protease inhibitors
34	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-08-21 15:16:08 Non-nucleoside reverse transcriptase inhibitors Pyridines Carbamates Sulfonamides Darunavir Lopinavir/ritonavir Etravirine Ritonavir Atazanavir Chemistry Organic chemistry Protease inhibitors
35	C:uments and SettingsND.FDAktopvir WL draftsvirL FINAL Draft (clean copy tracking sheet).doc Add to Reading List Source URL: www.fda.gov Language: English Ritonavir Lopinavir/ritonavir Antiretroviral drug Lopinavir Saquinavir Efavirenz Atazanavir Nelfinavir Abbott Laboratories Chemistry Organic chemistry Protease inhibitors
36	AIDS InfoNet[removed]www.aidsinfonet.org Fact Sheet Number 554[removed]DIARRHEA WHAT IS DIARRHEA? Add to Reading List Source URL: aidsinfonet.org Language: English - Date: 2014-02-05 12:43:05 Microbiology Diarrhea Lactobacillus acidophilus AIDS Lopinavir/ritonavir Nelfinavir Infectious diarrhea Wilderness acquired diarrhea Medicine Health Waterborne diseases
37	The Trans-Pacific Partnership Agreement (TPP) threatens access to affordable medicines The Trans-Pacific Partnership Agreement (TPP), a proposed trade deal between 12 Asia-Pacific countries including the United States, w Add to Reading List Source URL: www.citizen.org Language: English - Date: 2014-01-17 19:37:13 Pharmacology Patent law Civil law Pharmaceutical industry Generic drug Patent Evergreening Test data exclusivity Lopinavir/ritonavir Pharmaceuticals policy Pharmaceutical sciences Intellectual property law
38	----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-09-18 15:40:59 Ritonavir Delavirdine Lopinavir Nelfinavir Antiretroviral drug Fosamprenavir Darunavir Atazanavir Protease inhibitors Chemistry Organic chemistry
39	• Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) • Women who are pregnant or may become pregnant (4, 8.1) • Nursing mothers (4, 8.3) ------------- Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-04-21 16:03:04 AstraZeneca Diols Pyrimidines Rosuvastatin Fenofibrate Lopinavir/ritonavir Hypertriglyceridemia Hyperlipidemia Hypercholesterolemia Chemistry Organic chemistry Statins
40	AIDS InfoNet[removed]www.aidsinfonet.org Fact Sheet Number 448 FOSAMPRENAVIR (Telzir, Lexiva) Add to Reading List Source URL: www.aidsinfonet.org Language: English - Date: 2014-02-05 12:36:08 Carbamates HIV/AIDS Sulfonamides Fosamprenavir Amprenavir Antiretroviral drug Lopinavir/ritonavir Efavirenz Prodrug Chemistry Organic chemistry Protease inhibitors

UPDATE